Insulin-like growth factor binding protein-3 in preterm infants with retinopathy of prematurity

Manizheh Mostafa Gharehbaghi1, Ali Peirovifar, Karim Sadeghi

  • 1Women's Reproductive Health Research Center, Department of Pediatrics and Neonatology, Tabriz University of Medical Sciences, Tabriz, Iran.

Insights

Lower levels of insulin-like growth factor binding protein -3 (IGFBP-3) are linked to retinopathy of prematurity (ROP) in premature infants. This suggests IGFBP-3 deficiency may play a role in the development of ROP.

Area of Science:

  • Neonatology
  • Ophthalmology
  • Endocrinology

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of vision loss in premature infants.
  • Understanding the pathogenesis of ROP is crucial for developing effective interventions.

Purpose of the Study:

  • To investigate the association between insulin-like growth factor binding protein -3 (IGFBP-3) and proliferative ROP.
  • To explore the potential role of IGFBP-3 in the disease's development in premature infants.

Main Methods:

  • A case-control study involving 71 preterm infants (≤32 weeks gestation).
  • 41 infants without ROP (control group) and 30 with severe ROP (case group).
  • Blood samples analyzed for IGFBP-3 levels using ELISA 6-8 weeks after birth.

Main Results:

  • Infants with proliferative ROP had significantly lower IGFBP-3 blood levels compared to controls (P=0.009).
  • Lower Apgar scores were observed in the ROP group.
  • Plasma IGFBP-3 levels showed 65.9% sensitivity and 66.7% specificity for vasoproliferative ROP.

Conclusions:

  • Significantly lower IGFBP-3 blood levels were found in premature infants with ROP.
  • IGFBP-3 deficiency is suspected to contribute to the pathogenesis of proliferative ROP.
Abstract

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...